Thyroid Cancer Recurrence: Integrating Surgical, Clinical, and Translational Research
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 20 April 2026 | Viewed by 23
Special Issue Editor
2. Clinic for Endocrine Surgery, University Clinical Centre of Serbia, Belgrade, Serbia
Interests: thyroid; parathyroid; adrenal; endocrine surgery
Special Issue Information
Dear Colleagues,
Thyroid cancer recurrence remains a significant clinical challenge, impacting patient outcomes across all histological subtypes. This Special Issue aims to highlight recent advances in the understanding, detection, and management of recurrent thyroid cancer, with an emphasis on integrating surgical expertise and clinical decision making with current developments in molecular risk stratification, imaging techniques, circulating biomarkers, and response-adapted follow-up strategies. We welcome original research articles, reviews, and case series addressing recurrence risk stratification, surgical innovations, diagnostic imaging, systemic therapies, and the management of rare or aggressive subtypes. By combining translational research with clinical perspectives, this Special Issue provides a platform for advancing comprehensive, evidence-based, and personalized treatment approaches to improve outcomes—particularly for patients with aggressive or radioiodine-refractory thyroid cancer.
Prof. Dr. Nikola Slijepčević
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thyroid cancer
- recurrence
- surgery
- clinical management
- aggressive subtypes
- rare subtypes
- biomarkers
- imaging
- translational research
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
